Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion

被引:8
|
作者
Lauder, Sarah N. [1 ]
Smart, Kathryn [1 ]
Bart, Valentina M. T. [1 ]
Pires, Ana [1 ]
Scott, Jake [1 ]
Milutinovic, Stefan [1 ]
Godkin, Andrew [1 ]
Vanhaesebroeck, Bart [2 ]
Gallimore, Awen [1 ]
机构
[1] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF14 4XN, Wales
[2] UCL, UCL Canc Inst, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England
基金
英国惠康基金;
关键词
REGULATORY T-CELLS; IMMUNE TOLERANCE; ACTIVATION; EXPRESSION; ENABLES; MEDIATE;
D O I
10.1038/s41416-022-01917-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Recent studies have demonstrated that blocking the PI3K delta signalling enzyme (by administering a small molecule inhibitor, PI-3065) can potently improve the anti-tumour T-cell response through direct inhibition of Tregs. This treatment also has a negative impact on MDSC numbers but the primary mechanism driving this effect has remained unclear. Methods The 4T1 breast cancer mouse model was used in combination with PI-3065 to gain insights into the effect of PI3K delta inhibition on MDSCs. Results PI-3065 treatment resulted in a concomitant reduction in MDSC expansion and tumour size. However, targeting Tregs independent of PI-3065 was also associated with reduced tumour volume and MDSC numbers. Surgical removal of tumours resulted in a rapid and significant decline in MDSC numbers, whilst ex vivo studies using cells from PI-3065-treated mice demonstrated no direct effect of the inhibitor on MDSC activity. Conclusions Our data suggest that MDSCs are not inhibited directly by PI-3065 treatment but that their reduced recruitment and immunosuppression within the tumour microenvironment is an indirect consequence of PI3K delta-inhibition-driven tumour control. This indicates that PI3K delta inhibition drives tumour immunity by breaking down multiple immunosuppressive pathways through both direct mechanisms (on Treg) and indirect mechanisms, secondary to tumour control (on MDSCs).
引用
收藏
页码:1595 / 1602
页数:8
相关论文
共 50 条
  • [41] Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo
    Rosborough, Brian R.
    Castellaneta, Antonino
    Natarajan, Sudha
    Thomson, Angus W.
    Turnquist, Heth R.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 91 (05) : 701 - 709
  • [42] Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors
    Zhang, Mengqi
    Wang, Lulu
    Liu, Wan
    Wang, Tian
    De Sanctis, Francesco
    Zhu, Lifang
    Zhang, Guizhong
    Cheng, Jian
    Cao, Qin
    Zhou, Jingying
    Tagliabue, Aldo
    Bronte, Vincenzo
    Yan, Dehong
    Wan, Xianchun
    Yu, Guang
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [43] Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors
    Zhang, Mengqi
    Wang, Lulu
    Liu, Wan
    Wang, Tian
    De Sanctis, Francesco
    Zhu, Lifang
    Zhang, Guizhong
    Cheng, Jian
    Cao, Qin
    Zhou, Jingying
    Tagliabue, Aldo
    Bronte, Vincenzo
    Yan, Dehong
    Wan, Xianchun
    Yu, Guang
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [44] Dual Inhibition of PI3K Delta and PI3K Gamma Isoforms to Prevent Graft-Versus-Host Disease By Limiting T Cell Expansion In Vivo
    Wang, Shuhua
    Passang, Tenzin
    Li, Yiwen
    Zhang, Hanwen
    Das, Pankoj Kumar
    Chen, Kevin
    Funk, Christopher R.
    Waller, Edmund K.
    BLOOD, 2022, 140 : 10219 - 10220
  • [45] Hematopoietic stem cell mobilization leads to the expansion of circulating myeloid-derived suppressor cells in multiple myeloma patients
    Aristova, T.
    Tyrinova, T.
    Batorov, E.
    Sergeevicheva, V.
    Sizikova, S.
    Ushakova, G.
    Ostanin, A.
    Chernykh, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S1463 - S1463
  • [46] MONOCYTIC MYELOID-DERIVED SUPPRESSOR CELL EXPANSION AFTER CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS INDUCES LYMPHOCYTE DYSFUNCTION
    Lesouhaitier, Mathieu
    Uhel, Fabrice
    Gregoire, Murielle
    Gacouin, Arnaud
    Frerou, Aurelien
    Gaudriot, Baptiste
    Bendavid, Claude
    Boukthir, Sarrah
    Le Tulzo, Yves
    Verhoye, Jean-Philippe
    Flecher, Erwan
    Roussel, Mikael
    Tarte, Karin
    Tadie, Jean-Marc
    SHOCK, 2022, 58 (06): : 476 - 483
  • [47] Tempering the Clinical Effects of Early Myeloid-derived Suppressor Cell Expansion in Severe Sepsis and Septic Shock Reply
    Uhel, Fabrice
    Camus, Christophe
    Gacouin, Arnaud
    Tadie, Jean-Marc
    Le Tulzo, Yves
    Roussel, Mikael
    Tarte, Karin
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (05) : 678 - 679
  • [48] NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion
    Ying Wu
    Congying Pu
    Yixian Fu
    Guoqiang Dong
    Min Huang
    Chunquan Sheng
    Acta Pharmaceutica Sinica B, 2022, 12 (06) : 2859 - 2868
  • [49] Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion
    Dugast, Anne-Sophie
    Haudebourg, Thomas
    Coulon, Flora
    Heslan, Michele
    Haspot, Fabienne
    Poirier, Nicolas
    de Silly, Romain Vuillefroy
    Usal, Claire
    Smit, Helga
    Martinet, Bernard
    Thebault, Pamela
    Renaudin, Karine
    Vanhove, Bernard
    JOURNAL OF IMMUNOLOGY, 2008, 180 (12): : 7898 - 7906
  • [50] Human myeloid-derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data
    De Zuani, Marco
    Hortova-Kohoutkova, Marcela
    Andrejcinova, Ivana
    Tomaskova, Veronika
    Sramek, Vladimir
    Helan, Martin
    Fric, Jan
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (07) : 1785 - 1791